Structural Heart Disease refers to abnormalities of the heart’s anatomy that affect how blood flows through the heart and great vessels. It is a clinical domain spanning diagnosis (imaging and hemodynamics) and treatment (medical therapy, catheter-based intervention, and surgery). The term is commonly used in cardiology, cardiothoracic surgery, echocardiography, and multidisciplinary “heart team” decision-making. It most often centers on cardiac valves, congenital defects, chambers, and adjacent structures such as the aorta.

A Cardiac Ward is a hospital inpatient unit dedicated to people with heart and vascular conditions. It is a care setting rather than a single test or procedure. It commonly supports acute care, monitoring, and treatment adjustment in cardiology. It is used in general hospitals and specialist cardiac centers, often alongside a coronary care unit (CCU) and cardiac catheterization services.

A Cardiac Clinic is a clinical service where patients are assessed and managed for heart and vascular conditions. It sits in the domain of cardiovascular diagnosis, risk stratification, and longitudinal therapy planning. It is commonly used in outpatient settings, but it can also support post-hospital follow-up and pre-procedure assessment. It often coordinates diagnostic testing, medications, lifestyle counseling, and referrals for procedures or surgery when needed.

A Cardiac Unit is a hospital-based clinical area dedicated to caring for patients with cardiovascular disease. It is part of acute care medicine and focuses on monitoring, diagnosis, and treatment of heart-related conditions. It is commonly used for patients needing close observation, continuous electrocardiogram (ECG) monitoring, and rapid intervention. Depending on the institution, it may function as a cardiology ward, a coronary care unit (CCU), or a cardiac intensive care unit (CICU).

Cardiac Telemetry is continuous electrocardiographic (ECG) monitoring performed at a distance. It is a diagnostic monitoring approach used in acute care cardiology and hospital medicine. It tracks heart rhythm and heart rate to detect clinically important changes over time. It is commonly used in emergency departments, telemetry wards, step-down units, and perioperative settings.

High Sensitivity Troponin is a blood test used to detect very small amounts of cardiac troponin released with myocardial (heart muscle) injury. It is a diagnostic test in cardiology and emergency medicine, most often used when evaluating chest pain and suspected acute coronary syndrome (ACS). It supports early diagnosis and risk stratification for myocardial infarction (MI), alongside the electrocardiogram (ECG) and clinical assessment. It can also be elevated in non-ischemic conditions, so results must be interpreted in context.

A Cardiac Biomarker Panel is a set of blood tests used to detect and monitor heart-related injury, stress, or inflammation. It is a diagnostic test in clinical cardiology and emergency medicine, not an anatomic structure or a procedure. It is commonly used in the evaluation of chest pain, suspected acute coronary syndrome (ACS), and acute dyspnea. Results are interpreted alongside the electrocardiogram (ECG), symptoms, and imaging such as echocardiography.

GRACE Score is a clinical risk stratification tool used in acute coronary syndromes (ACS). It estimates the probability of death and other adverse outcomes using bedside clinical data. It is most commonly applied in emergency and inpatient cardiology for unstable angina and myocardial infarction. It supports decisions about monitoring intensity and invasive versus conservative strategies.

TIMI Score is a clinical risk-stratification tool used in cardiology. It estimates short-term risk in patients with suspected or confirmed acute coronary syndrome (ACS). It is most commonly applied in unstable angina (UA) and non–ST-elevation myocardial infarction (NSTEMI), and there is also a version for ST-elevation myocardial infarction (STEMI). It helps clinicians communicate risk and choose an appropriate evaluation and treatment pathway.

HAS BLED Score is a clinical risk score that estimates bleeding risk in patients considered for oral anticoagulation. It is used in cardiology as a risk stratification tool, most often in atrial fibrillation (AF). The score summarizes common bleeding risk factors into a single, structured checklist. It is commonly applied when balancing stroke prevention against bleeding risk during anticoagulant decision-making.